Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2019-09-26 Director's Dealing
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2019-09-26 English
FORM 4
Director's Dealing
2019-09-26 English
SC 13D/A
Major Shareholding Notification
2019-09-17 English
FORM 4
Director's Dealing
2019-09-17 English
FORM 4
Director's Dealing
2019-09-17 English
SC TO-T/A Filing
Merger & Acquisition Classification · 100% confidence The document is a Schedule TO filing with the SEC, specifically an Amendment No. 3 to a Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934. It details the terms, results, and payment information related to a tender offer for stock options by Medpace Investors, LLC and August J. Troendle. The document includes transaction valuation, filing fee calculation, and certification by the offeror. This type of filing is related to a tender offer transaction, which falls under merger and acquisition activity filings. Therefore, the appropriate classification is Merger & Acquisition (MA). The document length is sufficient and contains substantive transaction details, not just an announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2019-09-17 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.